Literature DB >> 9029410

Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients.

W Kuhn1, T Müller, H Grosse, H Rommelspacher.   

Abstract

Death of dopaminergic neurons in Parkinson's disease (PD) may partially be caused by synthesis and accumulation of endogenous and exogenous toxins. Because of structural similarity to MPTP, beta-carbolines, like norharman and harman, have been proposed as putative neurotoxins. In vivo they may easily be formed by cyclization of indoleamines with e.g. aldehydes. For further elucidation of the role of beta-carbolines in neurodegenerative disorders harman and norharman levels in cerebrospinal fluid (CSF) were measured in 14 patients with PD and compared to an age- and sex-matched control group (n = 14). CSF levels of norharman and harman in PD were significantly higher compared to controls. These results may suggest a possible role of harman and norharman or its N-methylated carbolinium ions in the pathophysiological processes initiating PD. However the origin of increased levels of these beta-carbolines remains unclear. On the one hand one may speculate, that unknown metabolic processes induce the increased synthesis of harman and norharman in PD. On the other hand a possible impact of exogenous sources may also be possible.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029410     DOI: 10.1007/BF01271257

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  Norharman, a normal body constituent.

Authors:  D Fekkes; M J Schouten; L Pepplinkhuizen; J Bruinvels; W Lauwers; U A Brinkman
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

2.  Similar inhibition of mitochondrial respiration by 1-methyl-4-phenyl-pyridinium (MPP+) and by a unique N-methylated beta-carboline analogue, 2,9-dimethyl-norharman (2,9Me2NH).

Authors:  J Z Fields; R Albores; E J Neafsey; M A Collins
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

3.  N-methylation of pyridines in Parkinson's disease.

Authors:  S Green; S Buttrum; H Molloy; G Steventon; S Sturman; R Waring; H Pall; A Williams
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

4.  Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances.

Authors:  L M Sayre; F J Wang; P K Arora; N J Riachi; S I Harik; C L Hoppel
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

5.  [Beta-carbolines (harman/norharman) are increased in heroin dependent patients].

Authors:  R Stohler; H Rommelspacher; D Ladewig; G Dammann
Journal:  Ther Umsch       Date:  1993-03

6.  Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine.

Authors:  R Albores; E J Neafsey; G Drucker; J Z Fields; M A Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Indole-N-methylated beta-carbolinium ions as potential brain-bioactivated neurotoxins.

Authors:  M A Collins; E J Neafsey; K Matsubara; R J Cobuzzi; H Rollema
Journal:  Brain Res       Date:  1992-01-20       Impact factor: 3.252

8.  Novel S-adenosylmethionine-dependent indole-N-methylation of beta-carbolines in brain particulate fractions.

Authors:  K Matsubara; E J Neafsey; M A Collins
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

9.  Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics.

Authors:  H Rommelspacher; L G Schmidt; T May
Journal:  Alcohol Clin Exp Res       Date:  1991-06       Impact factor: 3.455

10.  Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.

Authors:  H Rommelspacher; T May; B Salewski
Journal:  Eur J Pharmacol       Date:  1994-01-24       Impact factor: 4.432

View more
  16 in total

1.  Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.

Authors:  Angela Cruz-Hernandez; Zeynep Sena Agim; Paola C Montenegro; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Neurotoxicology       Date:  2018-03       Impact factor: 4.294

Review 2.  Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Authors:  Toshi Nagatsu; Makoto Sawada
Journal:  Cell Mol Neurobiol       Date:  2006-07-06       Impact factor: 5.046

3.  Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells.

Authors:  Won Tae Choi; Young Chul Youn; Eun Sook Han; Chung Soo Lee
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

4.  Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.

Authors:  A Ostergren; A Fredriksson; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

5.  Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.

Authors:  Zeynep Sena Agim; Jason R Cannon
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

6.  Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness.

Authors:  Elan D Louis; Wei Zheng; Wendy Jiang; Kenneth T Bogen; Garrett A Keating
Journal:  J Toxicol Environ Health A       Date:  2007-06

7.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

8.  Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Xinhua Liu; Jean-Paul G Vonsattel; Monika Galecki; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-08-02       Impact factor: 4.294

9.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

10.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.

Authors:  Elan D Louis; Monika Michalec; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-12-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.